The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
0.9804
+0.0344 (3.64%)
Apr 24, 2025, 4:00 PM EDT - Market closed
The Beauty Health Company Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for The Beauty Health Company stock have an average target of 2.50, with a low estimate of 1.00 and a high estimate of 5.00. The average target predicts an increase of 155.00% from the current stock price of 0.98.
Analyst Consensus: Hold
* Price targets were last updated on Mar 13, 2025.
Analyst Ratings
The average analyst rating for The Beauty Health Company stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 6 | 3 | 3 |
| Sell | 3 | 3 | 3 | 3 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.75 → $1.5 | Hold | Maintains | $1.75 → $1.5 | +53.00% | Mar 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.25 → $1.75 | Hold | Maintains | $1.25 → $1.75 | +78.50% | Nov 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | +27.50% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Sell Reiterates $1.5 → $1 | Sell | Reiterates | $1.5 → $1 | +2.00% | Aug 9, 2024 |
| Stifel | Stifel | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +104.00% | Jul 26, 2024 |
Financial Forecast
Revenue This Year
294.23M
from 334.29M
Decreased by -11.98%
Revenue Next Year
315.36M
from 294.23M
Increased by 7.18%
EPS This Year
-0.27
from -0.36
EPS Next Year
-0.21
from -0.27
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 311.9M | 351.1M | 407.6M |
| Avg | 294.2M | 315.4M | 369.3M |
| Low | 273.7M | 284.3M | 329.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -6.7% | 19.3% | 29.3% |
| Avg | -12.0% | 7.2% | 17.1% |
| Low | -18.1% | -3.4% | 4.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.14 | -0.05 | -0.26 |
| Avg | -0.27 | -0.21 | -0.28 |
| Low | -0.42 | -0.34 | -0.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.